Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Telomere reduction in hematologic cells

O Yamada1, K Oshimi, H Mizoguchi

  • 1Department of Medicine, Tokyo Women's Medical College, Japan.

International Journal of Hematology
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute antinociceptive tolerance and asymmetric cross-tolerance between endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse.

The Journal of pharmacology and experimental therapeutics·2001
Same author

Reduced hyperalgesia induced by nerve injury, but not by inflammation in mice lacking protein kinase C gamma isoform.

European journal of pharmacology·2001
Same author

[Mitral valve stenosis due to primary cardiac granulocytic sarcoma relapsing 8 years after complete remission: a case report].

Journal of cardiology·2001
Same author

Protective effect of rebamipide on indomethacin-induced intestinal damage in rats.

Journal of gastroenterology and hepatology·2001
Same author

[Physiopathology and treatment of refractory anemia].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·2001
Same author

[A case of gastrointestinal stromal tumor of rectum, difficult to differentiate from leiomyosarcoma of prostate].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology·2001
Same journal

Allogeneic hematopoietic cell transplantation with reduced-toxicity conditioning for X-linked hyper-IgM syndrome.

International journal of hematology·2026
Same journal

Incidence, etiology, and predictors of early mortality after induction chemotherapy for aml in a middle-income country.

International journal of hematology·2026
Same journal

Modified short-course fludarabine-based conditioning regimen for salvage cord blood transplantation after graft failure.

International journal of hematology·2026
Same journal

Cytarabine-based induction and oral maintenance therapy for a single system with single-site Langerhans cell histiocytosis.

International journal of hematology·2026
Same journal

Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.

International journal of hematology·2026
Same journal

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

International journal of hematology·2026
See all related articles

Telomeres, the protective caps on chromosomes, shorten in certain blood cancer cells. This study observed significant telomere length reduction and copy number decrease in leukemic cells, suggesting a potential diagnostic marker.

Area of Science:

  • Genetics
  • Molecular Biology
  • Oncology

Background:

  • Chromosome ends, known as telomeres, are crucial for genomic stability.
  • Tumor cells often exhibit aberrant telomere dynamics, including tandem fusion.
  • Understanding telomere alterations in hematologic malignancies is vital.

Observation:

  • Southern blot analysis revealed variations in telomere length (10-12 kb) in normal peripheral blood mononuclear cells.
  • Significant telomere sequence reduction (2-4 kb) and diminished signal intensity were observed in HL-60 and K562 cell lines.
  • Telomeric DNA array reduction was also noted in two tested leukemic cases.

Findings:

  • Leukemic cells showed reduced peak telomere length (5 and 4 kb pre-treatment vs. 10 and 7 kb post-treatment).

Related Experiment Videos

  • One case exhibited a ~50% reduction in telomere copy number post-treatment.
  • Alu and alphoid sequences remained unchanged, indicating telomere-specific DNA alterations.

    • Implications:

    • Telomere length and copy number changes are specific to telomeric regions in leukemic cells.
    • Assessing telomeric DNA alterations may provide insights into the biological significance of leukemia.
    • These findings could contribute to developing novel diagnostic or prognostic tools for hematologic cancers.